Avalon Investment & Advisory Eli Lilly & CO Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Eli Lilly & CO stock. As of the latest transaction made, Avalon Investment & Advisory holds 62,151 shares of LLY stock, worth $49.1 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

62,151

Previous 63,694 2.42%

Holding current value

$49.1 Million

Previous $23.3 Million 8.41%

% of portfolio

0.6%

Previous 0.66%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $479,302 - $562,917	-1,543 Reduced 2.42%	62,151 $21.3 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $20.5 Million - $23.9 Million	63,694 New	63,694 $23.3 Million
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $812,475 - $1.05 Million	-4,500 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $295,776 - $382,896	-1,800 Reduced 28.57%	4,500 $841,000
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $94,713 - $125,329	-726 Reduced 10.33%	6,300 $1.06 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $22,371 - $25,876	-153 Reduced 2.13%	7,026 $1.04 Million
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $68,073 - $81,925	-499 Reduced 6.5%	7,179 $1.18 Million
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $543,344 - $672,505	-4,564 Reduced 37.28%	7,678 $1.07 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $2,673 - $3,310	-25 Reduced 0.2%	12,242 $1.61 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $744,646 - $809,983	-6,973 Reduced 36.24%	12,267 $1.37 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $11.6 Million - $13.5 Million	-104,696 Reduced 84.48%	19,240 $2.13 Million
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $798,315 - $939,675	-7,172 Reduced 5.47%	123,936 $16.1 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $3.4 Million - $3.8 Million	32,068 Added 32.38%	131,108 $15.2 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $14.2 Million - $17.7 Million	-164,897 Reduced 62.48%	99,040 $10.6 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $755,334 - $866,888	-9,978 Reduced 3.64%	263,937 $22.5 Million
Q1 2018 Jun 26, 2018	BUY	$74.21 - $87.6 $71,612 - $84,534	965 Added 0.35%	273,915 $21.2 Million
Q1 2018 Jun 22, 2018	SELL	$74.21 - $87.6 $632,194 - $746,264	-8,519 Reduced 3.03%	272,950 $23.1 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $632,194 - $746,264	8,519 Added 3.12%	281,469 $21.8 Million
Q4 2017 Jun 22, 2018	SELL	$81.94 - $87.89 $1.2 Million - $1.29 Million	-14,681 Reduced 5.1%	272,950 $23.1 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $3.52 Million - $3.78 Million	42,989 Added 17.57%	287,631 $24.3 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $132,252 - $146,786	1,716 Added 0.71%	244,642 $20.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	242,926	242,926 $20 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Eli Lilly & CO Transaction History